Claim OwnershipPharmaTalkRadio
Subscribed: 10Played: 49
Subscribe
© Copyright Conference Forum
Description
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
523 Episodes
Reverse
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech companies development from preclinical to early stage to late stage trials to commercialization. Specifically:Balancing the mix of hires and outsourcingHiring for skillsets to enable efficiency without overhiringReactive vs proactive hiringBuilding in a stage appropriate way but also hiring in time for later stagesTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
1While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles.In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:Where LNPs potentially fall shortWhere different tools can enable therapeutic deliveryChallenges to achieving meaningful clinical impact for these different vehiclesBuilding out a portfolio of delivery vehiclesTo learn more about the PODD Conference, please visit Drug-Delivery.org.
About this podcast: This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:Engaging all stakeholders in designing the platformThe evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sourcesImpact of the advanced data analysis capabilities for risk managementReview of impact on initial studies now using the platform For more information, go to DPHARMconference.com.
About this podcast: Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also shed light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.The significant shift towards bringing clinical trials directly to local communities through various innovative models is noteworthy. Many new clinical trial execution models have been introduced during the past decade including site staff embedded within clinical care settings, remote sites, retail pharmacies, urgent care facilities, and mobile units going directly into local communities. This session comes from the 2025 Partnerships with Sites Summit.
About this podcast:This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center. Dr Rosenberg focuses on: The background and previous data of immune checkpoint blockade as monotherapy and in combination with chemotherapy, in urothelial cancerThe potential role of Immunogenic Cell Death and whether it has a clinical impact on patient care and creating an anti-tumor immune responseEnfortumab vedotin, an ADC targeting Nectin-4For more information, go to IO360summit.com.
About this podcast:This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. Specifically, this podcast dives deeper into: An introduction to radioligand therapyA focus on PSMA-targeted radionuclide therapyPrelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level For more information, visit IO360summit.com
About this episode:In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: J&J’s approach to patient centricity across the enterpriseHer thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex scienceMoving risk benefit assessments earlier into clinical development and the necessary change managementIncorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real worldFor more information, go to PatientsasPartnersConference.com.
In this podcast, Nicole Murphy, EVP and Head of Pharmaceutical Operations & Technology at Biogen, discusses:Cross-functional collaboration to deliver valueHow Biogen is using AI to enhance innovationSupply chain simplificationBiogen's partnership philosophy as it relates to drug deliveryTheir recent $2 billion manufacturing investment in the Research Triangle ParkAnd Biogen's acquisition of Alcyone Therapeutics It's an enlightening look into what real leadership in drug delivery, manufacturing and supply chain management looks like. For more information, go to Drug-Delivery.org.
In this podcast, Kate Woda, Conference Director of the Immuno-Oncology 360° Summit, discusses what attendees can expect at the 12th annual event, including key topic areas, session highlights, presenting companies and more.For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com.
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with CMOs and advisory solutions firms about how CMOs can work with consultants and fractional talent to stay on budget while getting the expertise needed. Specifically:Different profiles of fractional consultantsWhat to look for in a consultant and how to ensure alignment with the teamScoping the role of fractional talent and iterating as company needs evolveHow to best work with firms representing fractional talentAdvice for CMOs thinking about consultingTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
About this podcast:This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com.
About this podcast:This podcast comes from the 2025 Patients as Partners in Clinical Research conference. This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participationSuccessful models for empowering local leaders and leveraging community-based networks to increase participationEvaluating the impact of outreach and engagement efforts on enrollment representation and overall care equityAnd moreFor more information, go to PatientsAsPartnersConference.com.
About this podcast: Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. More specifically, Ms Thompson discusses how Roche is: Leveraging historical amendment data to enable study teams to understand why protocols are being amendedUtilizing a visual data science platform to generate insights from data to make better data-driven decisionsApplying retrospective learning into current protocols to curb the need for amendmentsBuilding in business value For more information, go to DPHARMconference.com.
About this podcast:This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference.Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaffiliated rural and frontier healthcare systems to empower them to meet clinical research demands without compromising local care delivery.More specifically, this presentation covers the tools created to toolkit empowers sites to do clinical research, including:Interpretable workflow templatesA workload calculator for staff capacity planningPatient safety indicators to support enrollment and retentionEHR-based visualization methods to assist clinical decision-making when trial participants are also patientsAnd moreFor more information, go to theconferenceforum.org.
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically:The importance of storytelling and leading thoughtfullyEffective prioritization and execution towards the company narrativeBalancing the team to be lean while avoiding the potential pitfalls of running leanBalancing the data collected to be interesting to investigators and important for the program to proceedClinical data generation is better than preclinical dreamsStrategically choosing a first indication and building sufficient scientific bridging to support subsequent indicationsTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
In this podcast from the DPHARM 2024 archives, Biogen discussed how they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients with a clinically validated cognitive assessment who might not otherwise have the foundation to start a conversation with their physician about their cognition. For more information, go to DPHARMconference.com
At the March 2025 Patients as Partners conference, Merck presents how they advancing patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. Key topics include:Identifying and addressing patient and community needsStrategies for earning trust and fostering sustained engagementKey collaborations and partnerships driving meaningful changeApproaches to developing patient-centered endpoints and outcomesMethods for effectively communicating and disseminating trial resultsFor more information, go to PatientsAsPartnersConference.com
Summary: This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teamsSuggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback, supporting a more integrated approach to patient engagementStrategies to build on existing insights, enhance collaboration across teams, and drive more effective patient-centered outcomes in R&D processesFor more information, go to PatientsAsPartnersConference.com.
Summary: From the DPHARM Archives, this podcast was recorded at the September 2024 DPHARM conference. In this podcast, BMS present how they specifically targeted the challenge of recruiting patients for clinical trials, aiming to make the process faster and easier. By bringing trials directly to patients, their ultimate objective was to significantly expedite patient enrollment. In this case example, they brought the audience through their new product model approach, for the organization's overarching goal of reducing the drug timeline from discovery to launch by three years.
About this podcast:Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader lessons on the evolution of cell therapy, and her forward-looking perspective on shaping the next generation of cancer treatments.For more information, go to IO360summit.com.
Comments
Download from Google Play
Download from App Store
United States